News
Mesa Police Chief Ken Cost will retire on June 30, marking the city's third major leadership change this year. Cost served as chief since 2019. During his tenure, Cost focused on community ...
The stalled GRID mixed-use development in downtown Mesa has a new owner, Soltrust Main QOZB LLC, after the previous developers filed for bankruptcy. Soltrust plans to complete the project in three ...
1-2 Special has acquired all North American rights for Simón Mesa Soto’s dark comedy “A Poet,” which premiered in Un Certain Regard at the Cannes Film Festival, where it won the jury prize.
Former Arkansas guard Boogie Fland is reportedly withdrawing from the 2025 NBA draft after briefly testing the process, according to Jonathan Givony of ESPN. Fland initially declared for the draft ...
Her slides just got added to my summer wishlist. Kaelin is a shopping and fashion writer for InStyle, covering fashion, beauty, and celebrities. She got her start in 2019. As fashion and beauty ...
The Indiana Fever holds a 3–4 record and ranks third in the Eastern Conference. Despite early challenges such as Caitlin Clark's quad strain and Sophie Cunningham's ankle injury, the team has ...
On Wednesday, 6-foot-4 combo guard Xavier Skipworth announced that he received an offer from the Boilermakers. Skipworth, who plays at The Bullis School in Potomac, Md., received an offer in the ...
LA MESA, Calif. — La Mesa residents are voicing concerns over persistent noise emanating from the City of San Diego's Alvarado Water Treatment Plant, disrupting their daily lives and exceeding ...
The combination of trastuzumab deruxtecan (Enhertu) with pertuzumab (Perjeta) as a first-line treatment for HER2-positive advanced metastatic breast cancer has been shown to reduce the risk for ...
See reviews below to learn more or submit your own review. La Mesa RV specializes in RV sales and services across multiple states. The company offers a selection of new and pre-owned motor homes ...
'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...
GSK's latecomer to the PD-1/PD-L1 inhibitor category Jemperli has barely started to bring in revenues, and is a world away from the company's hopes of blockbuster revenues by 2031. The drugmaker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results